查找临床试验

已按「宫颈癌」检索,对应国际通用词 cervical cancer

试验不在中国怎么办?

共找到 715 项正在招募的试验(在中国/港澳台设有中心)

数据更新于 23:03,每 5 分钟自动同步
正在招募不适用中国有中心NCT06019455

The Level of Patient Participation in Lung and Esophageal Cancer Patients Treated With Definitive Radiochemotherapy.

China

年龄 18 Years – 75 Years

Sun Yat-sen University

正在招募不适用中国有中心NCT07326358

AI System for Anatomic Recognition & Lesion Detection in Nasopharyngolaryngoscopy: A Prospective Study

China

年龄 18 Years – 不限

Ruijin Hospital

正在招募II 期中国有中心NCT05941338

Tirelizumab in Combination With Carboplatin and Albumin-binding Paclitaxel for Neoadjuvant Therapy in HNSCC

China

年龄 18 Years – 65 Years

Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University

正在招募I 期 / II 期中国有中心NCT06780111

Substudy 06E: Umbrella Study of Combination Therapies in Esophageal Cancer (MK-3475-06E/KEYMAKER-U06)

United States、Brazil、Chile、China、Czechia 等 12 国

年龄 18 Years – 不限

Merck Sharp & Dohme LLC

正在招募I 期 / II 期中国有中心NCT07367516

Clinical Trial Evaluating TQB6411 Injection in Participant s With Esophageal Cancer

China

年龄 18 Years – 75 Years

Chia Tai Tianqing Pharmaceutical Group Co., Ltd.

正在招募II 期中国有中心NCT07692204

A Dose Optimization/Expansion Study of SAR445877 in Adult Chinese Participants With Advanced Gastric or Gastroesophageal Junction Cancer

China

年龄 18 Years – 不限

Sanofi

正在招募I 期 / II 期中国有中心NCT05937438

Postoperative Radiotherapy Followed by Immunotherapy for Locally Advanced Esophageal Carcinoma

China

年龄 18 Years – 75 Years

Anhui Provincial Hospital

正在招募II 期中国有中心NCT04807140

Neoadjuvant Toripalimab or Toripalimab in Combination With Carboplatin and Nab-paclitaxel in Untreated HNSCC (HNSCC-002)

China

年龄 18 Years – 80 Years

Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University

正在招募I 期中国有中心NCT05366478

A Clinical Study of LM103 Injection in the Treatment of Advanced Solid Tumors

China

年龄 18 Years – 不限

Suzhou BlueHorse Therapeutics Co., Ltd.

正在招募I 期 / II 期中国有中心NCT05803018

A Study of BL-B01D1 in Patients With Multiple Solid Tumors, Including Recurrent or Metastatic Gynecological Malignancies

China

年龄 18 Years – 75 Years

Sichuan Baili Pharmaceutical Co., Ltd.

正在招募II 期中国有中心NCT06843889

A Phase II Study of Toripalimab Combined With Sequential Neoadjuvant Chemoradiotherapy in Patients With Esophageal Squamous Cell Carcinoma

China

年龄 18 Years – 75 Years

Nanfang Hospital, Southern Medical University

正在招募不适用中国有中心NCT07557225

18F-T2 PET/CT Imaging for CAIX Positive Solid Tumors

China

年龄 18 Years – 不限

Peking University First Hospital